The legacy of Sildenafil offers a complex case study for investors eyeing the pharmaceutical sector. While early sales were explosive, recent patent lapse and the emergence of generic versions have considerably affected earnings. Moreover, growing regulatory scrutiny and demands to lower medication prices pose persistent challenges. Thus, bettin… Read More

The emergence of so-called "High Roller The Pill" – often referring to exceptionally high doses prescribed by unscrupulous physicians – represents a unusually alarming trend. While typical dosages of Sildenafil are intended for treating erectile dysfunction safely in most individuals, these significantly elevated doses pose a grave hazard to ci… Read More